Adar Poonawalla, CEO of Serum Institute of India and a leader in global vaccine production, shares insights from the World Economic Forum. He discusses the impact of Trump's withdrawal from the WHO and strides made in vaccine equity. Key projects like the HPV vaccine, along with innovations in malaria and dengue vaccine development, are highlighted. Poonawalla reveals a $2 billion investment focused on cutting-edge research and the integration of AI in clinical trials, while also diversifying into films and music. A captivating blend of health and business!